Spear Bio Inc. raised $45M in a Series A financing co-led by Foresite Capital and Bio-Techne Corporation to accelerate the launch of protein research and disease diagnostics products.
Amount Raised
$45 Million
Round Type
Series A
WoburnBiotechnologyInvestors
Description
Spear Bio Inc. announced the successful closing of its $45 million Series A financing, aimed at advancing their innovative protein measurement technology. The round was oversubscribed and included participation from notable investors including Maverick Ventures and Yonjin Capital.
Quick answer
Spear Bio raised $45 Million in a Series A round, dated July 29, 2024. Investors: CDH Investments, Yonjin Capital, Maverick Ventures, Bio Techne Corporation and Foresite Capital. Spear Bio is based in Woburn, Massachusetts, United States.
- How much did Spear Bio raise?
- Spear Bio raised $45 Million in a Series A round on July 29, 2024.
- Who invested in Spear Bio?
- CDH Investments, Yonjin Capital, Maverick Ventures, Bio Techne Corporation and Foresite Capital are named as investors in this round.
- What does Spear Bio do?
- Spear Bio – founded in 2021 and headquartered in Woburn, Massachusetts – is an innovative leader in providing scalable solutions for ultra-sensitive protein biomarker measurements.
- Where is Spear Bio based and how big is it?
- Spear Bio is based in Woburn, Massachusetts, United States.
- Who are the decision-makers at Spear Bio?
- Fundz holds 1 contact at Spear Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Spear Bio that raised within 45 days of this round, from Fundz verified event records.
- Oruka Therapeutics raised $200M (Post-IPO Equity) on September 12, 2024.
- Sinopia Biosciences raised $2.2M (Seed) on September 12, 2024.
- Novameat raised $19M (Series A) on September 12, 2024.
- Wundrsight raised $400K (Seed) on September 12, 2024.
- XS Innovations raised $1.2M (Seed) on September 12, 2024.
- Inflammatix raised $57M (Series E) on September 12, 2024.
Who to call at Spear Bio, and when
A new round usually means Spear Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Spear Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Spear Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Spear Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Spear Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSpear Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.